Combining Immune Checkpoint Inhibitors with Anti-Angiogenic Agents

Journal of Clinical Medicine
Paola CiciolaRoberto Bianco

Abstract

Immunotherapy has recently emerged as a novel strategy for treating different types of solid tumors, with promising results. However, still a large fraction of patients do not primarily respond to such approaches, and even responders sooner or later develop resistance. Moreover, immunotherapy is a promising strategy for certain malignancies but not for others, with this discrepancy having been attributed to a more immunogenic microenvironment of some tumors. As abnormal and augmented tumor vessels often occur in cancerogenesis, anti-angiogenic drugs have already demonstrated their effectiveness both in preclinical and in clinical settings. By targeting abnormal formation of tumor vessels, anti-angiogenetic agents potentially result in an enhanced infiltration of immune effector cells. Moreover, crosstalks downstream of the immune checkpoint axis and vascular endothelial growth factor receptor (VEGFR) signaling may result in synergistic effects of combined treatment in tumor cells. In this review, we will describe and discuss the biological rationale of a combined therapy, underlying the modification in tumor microenvironment as well as in tumor cells after exposure to checkpoint inhibitors and anti-angiogenic drugs. Moreover, w...Continue Reading

References

Nov 18, 1971·The New England Journal of Medicine·J Folkman
Mar 1, 1994·Journal of Leukocyte Biology·C SunderkötterC Sorg
Jun 1, 1996·The Journal of Experimental Medicine·M F Krummel, J P Allison
Apr 22, 2003·Nature Medicine·Tyler J CurielWeiping Zou
Jun 5, 2003·Nature Medicine·Napoleone FerraraJennifer LeCouter
Jun 4, 2004·The New England Journal of Medicine·Herbert HurwitzFairooz Kabbinavar
Dec 3, 2005·Cancer Research·Adriana AlbiniDouglas M Noonan
Dec 7, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Robert J MotzerBrian I Rini
Mar 23, 2006·Annual Review of Immunology·Wendy A TeftJoaquín Madrenas
Apr 4, 2006·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Anita E M DirkxArjan W Griffioen
Apr 22, 2006·Contributions to Microbiology·Karin E de Visser, Lisa M Coussens
Sep 29, 2006·Cancer Metastasis Reviews·Gera Neufeld, Ofra Kessler
Dec 15, 2006·The New England Journal of Medicine·Alan SandlerDavid H Johnson
Dec 23, 2006·Nature Reviews. Immunology·Hua YuDrew Pardoll
Apr 20, 2007·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Bruce J GiantonioUNKNOWN Eastern Cooperative Oncology Group Study E3200
Jul 4, 2007·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Elizabeth A ManningLeisha A Emens
Aug 25, 2007·Cancer Metastasis Reviews·Femke Hillen, Arjan W Griffioen
Jan 5, 2008·Annual Review of Immunology·Mary E KeirArlene H Sharpe
May 9, 2008·The New England Journal of Medicine·Robert S Kerbel
Jun 21, 2008·The Journal of Immunology : Official Journal of the American Association of Immunologists·Sergei KusmartsevJohannes Vieweg
Jul 18, 2008·Nature Reviews. Cancer·Craig MurdochClaire E Lewis
Oct 18, 2008·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·James H FinkeRonald Bukowski
Nov 26, 2008·Nature Reviews. Cancer·Christian FischerPeter Carmeliet
Feb 4, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Martin ReckChristian Manegold
May 20, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Bernard EscudierRonald M Bukowski
Jan 27, 2010·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Cora N SternbergRobert E Hawkins
Feb 10, 2010·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·David J GallagherDean F Bajorin
Jun 8, 2010·The New England Journal of Medicine·F Stephen HodiWalter J Urba
Nov 16, 2010·Annual Review of Pathology·William A Muller
Dec 21, 2010·International Journal of Cancer. Journal International Du Cancer·Anamika BoseWalter J Storkus
Jun 7, 2011·The New England Journal of Medicine·Caroline RobertJedd D Wolchok
Jun 10, 2011·Journal of Immunotherapy·Valerie P GrignolWilliam E Carson
Dec 21, 2011·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Toni K ChoueiriPhilip W Kantoff
Mar 23, 2012·Nature Reviews. Cancer·Matthew Vanneman, Glenn Dranoff
Jun 5, 2012·The New England Journal of Medicine·Suzanne L TopalianMario Sznol

❮ Previous
Next ❯

Citations

Apr 30, 2020·Biomolecules·Evangelos KoustasMichalis V Karamouzis
Oct 13, 2020·Frontiers in Cell and Developmental Biology·Hasan Korkaya, Sandra Orsulic
Feb 20, 2021·Seminars in Cancer Biology·M CummingsN M Orsi
Dec 12, 2020·Acta Pharmaceutica Sinica. B·Yang ZhaoJia Li
Apr 10, 2021·Nature Reviews. Clinical Oncology·Zowi R HuinenArjan W Griffioen
Apr 16, 2021·Frontiers in Immunology·Morgane BourhisMagali Terme
Jun 1, 2021·Expert Opinion on Therapeutic Targets·Yasser TabanaKhaled Barakat
Jun 15, 2021·Frontiers in Oncology·Agnese MontaninoAlessandro Morabito
Jul 3, 2021·Journal of Clinical Medicine·Anne Dyhl-PolkDorte Lisbet Nielsen
Jul 25, 2021·Cancers·Lynn BitarMirko H H Schmidt
Jul 24, 2021·Biomarker Research·Wuzhen ChenZhigang Chen
Jul 25, 2021·International Journal of Molecular Sciences·Albina FejzaEva Andreuzzi
Jul 25, 2021·Journal for Immunotherapy of Cancer·Julien FagetNathalie Bonnefoy

❮ Previous
Next ❯

Methods Mentioned

BETA
xenograft
xenografts
biopsy
biopsies

Software Mentioned

MODUL
SEQUEL

Related Concepts

Related Feeds

Angiogenesis Inhibitors to Treat Cancer

Cancer treatments including angiogenesis inhibitors prevent tumor cells from receiving nutrients and oxygen. Here is the latest research on angiogenesis inhibitors for the treatment of cancer.

Related Papers

Current Cancer Drug Targets
Nicolas AndréJaroslav Sterba
Clinical & Developmental Immunology
Magali TermeJulien Taieb
Japanese Journal of Clinical Oncology
Junko Iwasaki, Shin-ichi Nihira
© 2021 Meta ULC. All rights reserved